Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure

European Heart Journal

Volumn 34, Issue 10, 2013, Pages 759-766

  Parati, Gianfranco ^a,b   Revera, Miriam ^a   Giuliano, Andrea ^a,b   Faini, Andrea ^a   Bilo, Grzegorz ^a   Gregorini, Francesca ^a   Lisi, Elisabetta ^a,b   Salerno, Sabrina ^a,b   Lombardi, Carolina ^a   Ramos Becerra, Carlos G ^a   Mancia, Giuseppe ^a,b   Salvi, Paolo ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Acetazolamide; Arterial stiffness; Blood pressure; High altitude; Hypobaric hypoxia; Pulse wave velocity

Indexed keywords

ACETAZOLAMIDE; PLACEBO;

ADULT; ALTITUDE; ALTITUDE DISEASE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HYPOXIA; MALE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL;

ACETAZOLAMIDE; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CARBONIC ANHYDRASE INHIBITORS; CAROTID ARTERY, COMMON; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OXYGEN; TIME FACTORS; VASCULAR STIFFNESS;

EID: 84874873952     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs140     Document Type: Article

References (38)

1. Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007; 116: 2191-2202.
2. Bilo G, Caldara G, Styczkiewicz K, Revera M, Lombardi C, Giglio A, Zambon A, Corrao G, Faini A, Valentini M, Mancia G, Parati G. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens 2011;29: 380-387.
3. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, Roman MJ, Safar ME, Segers P, Smulyan H. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009;54: 375-383.
4. Giannattasio C, Failla M, Lucchina S, Zazzeron C, Scotti V, Capra A, Viscardi L, Bianchi F, Vitale G, Lanzetta M, Mancia G. Arterial stiffening influence of sympathetic nerve activity: evidence from hand transplantation in humans. Hypertension 2005;45: 608-611.
5. Failla M, Grappiolo A, Emanuelli G, Vitale G, Fraschini N, Bigoni M, Grieco N, Denti M, Giannattasio C, Mancia G. Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. J Hypertens 1999;17: 1117-1123.
6. Ting CT, Chou CY, Chang MS, Wang SP, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. Effects of adrenergic blockade. Circulation 1991;84: 1049-1057.
7. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 2007;102: 1313-1322.
8. Ried L, Carter K, Ellsworth A. Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis. J Wilderness Med 1994;5: 34-48.
9. Birmingham Medical Research Expeditionary Society Mountain Sickness Study Group. Acetazolamide in control of acute mountain sickness. Lancet 1981;1: 180-183.
10. Cain SM, Dunn JE II. Low doses of acetazolamide to aid accommodation of men to altitude. J Appl Physiol 1966;21: 1195-1200.
11. Imray C, Booth A, Wright A, Bradwell A. Acute altitude illnesses. BMJ 2011;343: d4943.
12. Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967;47: 595-781.
13. Swenson ER, Hughes JM. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 1993;74: 230-237.
14. Teppema LJ, Rochette F, Demedts M. Ventilatory response to carbonic anhydrase inhibition in cats: effects of acetazolamide in intact vs. peripherally chemodenervated animals. Respir Physiol 1988;74: 373-382.
15. Vovk A, Duffin J, Kowalchuk JM, Paterson DH, Cunningham DA. Changes in chemoreflex characteristics following acute carbonic anhydrase inhibition in humans at rest. Exp Physiol 2000;85: 847-856.
16. Wagenaar M, Teppema L, Berkenbosch A, Olievier C, Folgering H. The effect of low-dose acetazolamide on the ventilatory Co2 response curve in the anaesthetized cat. J Physiol 1996;495 (Pt 1): 227-237.
17. West JB. The physiologic basis of high altitude diseases. Ann Intern Med 2004;141: 789-800.
18. Swenson ER. Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction. Respir Physiol Neurobiol 2006;151: 209-216.
19. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. In vivo evidence for k(ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol 2001;132: 443-450.
20. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 2009;297: H2068-H2074.
21. Bartsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW. Acute mountain sickness: controversies and advances. High Alt Med Biol 2004;5: 110-124.
22. Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis 2010;52: 467-484.
23. Roach R, Ba?rtsch P, Oelz O, Hackett PH. The Lake Louise Acute Mountain Sickness Scoring System. Hypoxia and Molecular Medicine. Burlington, VT: Queen City Press; 1993.
24. Joly L, Perret-Guillaume C, Kearney-Schwartz A, Salvi P, Mandry D, Marie PY, Karcher G, Rossignol P, Zannad F, Benetos A. Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension 2009;54: 421-426.
25. Salvi P, Lio G, Labat C, Ricci E, Pannier B, Benetos A. Validation of a new noninvasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the pulsepen device. J Hypertens 2004;22: 2285-2293.
26. NicholsW, O'Rourke M. Mcdonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. 5th ed. London: Edward Arnold; 2005.
27. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000;525 (Pt 1): 263-270.
28. Koller EA, Drechsel S, Hess T, Macherel P, Boutellier U. Effects of atropine and propranolol on the respiratory, circulatory, and ECG responses to high altitude in man. Eur J Appl Physiol Occup Physiol 1988;57: 163-172.
29. Lahiri S, Mulligan E, Mokashi A. Adaptive response of carotid body chemoreceptors to Co2. Brain Res 1982;234: 137-147.
30. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, Umans JG, Calhoun D, Howard BV. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009;54: 1730-1734.
31. Hainsworth R, Drinkhill MJ, Rivera-Chira M. The autonomic nervous system at high altitude. Clin Auton Res 2007;17: 13-19.
32. Thomson AJ, Drummond GB, Waring WS, Webb DJ, Maxwell SR. Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. J Appl Physiol 2006;101: 809-816.
33. Nichols WW, Denardo SJ, Wilkinson IB, McEniery CM, Cockcroft J, O'Rourke MF. Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich) 2008;10: 295-303.
34. Bashir Y, Kann M, Stradling Jr. The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects. Pulm Pharmacol 1990;3: 151-154.
35. Lassen NA. Is central chemoreceptor sensitive to intracellular rather than extracellular pH? Clin Physiol 1990;10: 311-319.
36. Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension 1999;33: 1043-1048.
37. Busch T, Bartsch P, Pappert D, Grunig E, Hildebrandt W, Elser H, Falke KJ, Swenson ER. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high altitude pulmonary edema. Am J Respir Crit Care Med 2001;163: 368-373.
38. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, Fikrle A, Ballmer PE, Nicod P, Bartsch P. Inhaled nitric oxide for high altitude pulmonary edema. N Engl J Med 1996;334: 624-629.